Free Trial
NASDAQ:SCYX

SCYNEXIS (SCYX) Stock Price, News & Analysis

SCYNEXIS logo
$0.73 +0.01 (+1.51%)
Closing price 02:22 PM Eastern
Extended Trading
$0.72 -0.02 (-2.19%)
As of 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SCYNEXIS Stock (NASDAQ:SCYX)

Key Stats

Today's Range
$0.72
$0.75
50-Day Range
$0.67
$1.03
52-Week Range
$0.66
$2.29
Volume
70,952 shs
Average Volume
161,476 shs
Market Capitalization
$28.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SCYNEXIS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

SCYX MarketRank™: 

SCYNEXIS scored higher than 6% of companies evaluated by MarketBeat, and ranked 2776th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for SCYNEXIS.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SCYNEXIS is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SCYNEXIS is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SCYNEXIS has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about SCYNEXIS's valuation and earnings.
  • Percentage of Shares Shorted

    1.68% of the float of SCYNEXIS has been sold short.
  • Short Interest Ratio / Days to Cover

    SCYNEXIS has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in SCYNEXIS has recently decreased by 3.00%, indicating that investor sentiment is improving.
  • Dividend Yield

    SCYNEXIS does not currently pay a dividend.

  • Dividend Growth

    SCYNEXIS does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.68% of the float of SCYNEXIS has been sold short.
  • Short Interest Ratio / Days to Cover

    SCYNEXIS has a short interest ratio ("days to cover") of 4.8.
  • Change versus previous month

    Short interest in SCYNEXIS has recently decreased by 3.00%, indicating that investor sentiment is improving.
  • Search Interest

    Only 8 people have searched for SCYX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SCYNEXIS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.86% of the stock of SCYNEXIS is held by insiders.

  • Percentage Held by Institutions

    54.37% of the stock of SCYNEXIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about SCYNEXIS's insider trading history.
Receive SCYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SCYNEXIS and its competitors with MarketBeat's FREE daily newsletter.

SCYX Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
Scynexis to present preclinical data on SCY-247 at ESCMID Meeting
SCYNEXIS Full Year 2024 Earnings: Misses Expectations
See More Headlines

SCYX Stock Analysis - Frequently Asked Questions

SCYNEXIS's stock was trading at $1.21 at the beginning of 2025. Since then, SCYX shares have decreased by 39.6% and is now trading at $0.7310.

SCYNEXIS, Inc. (NASDAQ:SCYX) issued its earnings results on Thursday, May, 15th. The company reported ($0.17) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.06. The firm earned $0.26 million during the quarter, compared to the consensus estimate of $0.14 million. SCYNEXIS had a negative net margin of 1,030.04% and a negative trailing twelve-month return on equity of 53.47%.

SCYNEXIS shares reverse split on the morning of Friday, July 17th 2020.The 1-10 reverse split was announced on Thursday, July 16th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 16th 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SCYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SCYNEXIS investors own include Zomedica (ZOM), Jumia Technologies (JMIA), NIO (NIO), Nano Dimension (NNDM), Sorrento Therapeutics (SRNE), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
5/15/2025
Today
7/03/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCYX
Employees
60
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.29 million
Net Margins
-1,030.04%
Pretax Margin
-1,044.49%

Debt

Sales & Book Value

Annual Sales
$3.75 million
Price / Cash Flow
N/A
Book Value
$1.45 per share
Price / Book
0.52

Miscellaneous

Free Float
37,124,000
Market Cap
$29.27 million
Optionable
Optionable
Beta
1.57

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SCYX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners